| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr9_0029100 | Intergenic-Intergenic | chr9:104316220-104316475 | chr9:101553938-101554193 | 256 nt | 0.4141 |
| hsa_RNF20_0002800 | Exon-Exon | chr9:104316976-104319878 | chr9:101554694-101557596 | 363 nt | 0.4628 |
| hsa_RNF20_0002900 | Exon-Exon | chr9:104319708-104319857 | chr9:101557426-101557575 | 150 nt | 0.4533 |
| hsa_RNF20_0003000 | Exon-Exon | chr9:104319813-104323100 | chr9:101557531-101560818 | 84 nt | 0.4881 |
| hsa_RNF20_0003100 | Intron-Intron | chr9:104322348-104323082 | chr9:101560066-101560800 | 735 nt | 0.3170 |
| hsa_RNF20_0003300 | Exon-Exon | chr9:104323083-104323512 | chr9:101560801-101561230 | 267 nt | 0.4757 |
| hsa_chr9_0029200 | Intergenic-Intergenic | chr9:104323181-104323401 | chr9:101560899-101561119 | 58 nt | 0.5172 |
A study in human breast cancer demonstrated that the circRNF20 promotes cancer cell proliferation and aerobic glycolysis via the miR-487a/HIF-1α/HK2 axis [Huang et al. DOI:10.3390/cells11091381].